Frequency
Shares of the company drop after announcing late-stage trial results that disappoint the Street.
5:59PM 08/12/08
Cystic Fibrosis candidate Trizytek performed better than a placebo in trials, but perhaps not as much as the FDA wanted.
2:20PM 08/12/08
EPIX plunges after ending development of its depression drug.
3:36PM 03/20/08
Omrix Biopharmaceuticals climbs on preliminary earnings results.
4:44PM 02/05/08
This week, Adam responds to reader inquiries about Xoma, Vanda and Onyx.
10:31AM 01/19/08
Failing a phase III trial is never a good thing. Don't believe a CEO's attempt to spin it otherwise.
1:44PM 12/21/07
The brokerage's stock finishes in positive territory despite a big quarterly loss.
5:51PM 12/20/07
Altus got its hormone drug, but gave up 40% in the market.
2:16PM 12/20/07
An investor meeting could help it break out.
1:22AM 06/20/07
Dendreon's big date, holding off on Threshold and where I get my paycheck.
1:11AM 06/20/07
Our Experts' Take at RealMoney
However, option traders boost January calls.
4:37PM 11/21/08
This market is producing a few stocks that could represent exceptional opportunities.
3:03PM 11/21/08
More Experts' Takes
More popular tickers are indicated by scale.
